A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The primary objective of this study is to assess the pharmacokinetics (PK) of AMG 133 after multiple subcutaneous (SC) administrations in participants with overweight or obesity using various dose regimens.
Epistemonikos ID: 5ad35ad15b9996309a1a47a3a26dabf015064290
First added on: May 17, 2025